Tejal Patel1,2, Jamie Milligan2,3, Joseph Lee2,3. 1. a University of Waterloo, School of Pharmacy , Waterloo , ON , Canada. 2. b The Centre for Family Medicine , Kitchener , ON , Canada. 3. c Department of Family Medicine , McMaster University , Hamilton , ON , Canada.
Abstract
OBJECTIVE: To determine the frequency of medical problems, reason for referral/primary complaint, products used, medication-related problems, and polypharmacy in patients with spinal cord injury (SCI) seen at an interprofessional primary care mobility clinic. DESIGN: Retrospective review of medical records of patients with SCI for patient visits between August 2012 and March 2013. METHODS: Data were abstracted from medical records of patients with SCI. RESULTS: Of 74 patients who presented to the clinic, 19 had an SCI. Mean age was 46.7 years and 74% were male. Most frequent medical problems were depression/anxiety (37%), osteoporosis/osteopenia (26%), hypertension (21%), dyslipidemia (21%), and osteoarthritis (21%). Most common presenting complaints were pain (23%) and bowel/bladder issues (13%). Most common medication-related problems were untreated conditions (41%), ineffective medications (21%), adverse drug reactions (18%), and under- and over-dosage (each 9%). Patients with SCI most frequently used products to treat pain (68%), constipation (42%), muscle spasm (42%), hypertension (42%), and depression (37%). When including natural health products, vitamins and minerals, polypharmacy was seen in 74% of patients with SCI (63% when limited to prescription and over-the-counter medications). For patients with SCI in whose care a pharmacist collaborated, a mean of 3.2 medication-related problems per patient were identified compared with 1 per patient when the pharmacist was not involved. CONCLUSION: This study is the first to describe medication use, polypharmacy and medication-related problems in patients with SCI seen at an interprofessional primary care clinic. Use of high-risk medications, polypharmacy, and medication-related problems in patients with SCI suggest the need for collaborative interprofessional care that includes a pharmacist.
OBJECTIVE: To determine the frequency of medical problems, reason for referral/primary complaint, products used, medication-related problems, and polypharmacy in patients with spinal cord injury (SCI) seen at an interprofessional primary care mobility clinic. DESIGN: Retrospective review of medical records of patients with SCI for patient visits between August 2012 and March 2013. METHODS: Data were abstracted from medical records of patients with SCI. RESULTS: Of 74 patients who presented to the clinic, 19 had an SCI. Mean age was 46.7 years and 74% were male. Most frequent medical problems were depression/anxiety (37%), osteoporosis/osteopenia (26%), hypertension (21%), dyslipidemia (21%), and osteoarthritis (21%). Most common presenting complaints were pain (23%) and bowel/bladder issues (13%). Most common medication-related problems were untreated conditions (41%), ineffective medications (21%), adverse drug reactions (18%), and under- and over-dosage (each 9%). Patients with SCI most frequently used products to treat pain (68%), constipation (42%), muscle spasm (42%), hypertension (42%), and depression (37%). When including natural health products, vitamins and minerals, polypharmacy was seen in 74% of patients with SCI (63% when limited to prescription and over-the-counter medications). For patients with SCI in whose care a pharmacist collaborated, a mean of 3.2 medication-related problems per patient were identified compared with 1 per patient when the pharmacist was not involved. CONCLUSION: This study is the first to describe medication use, polypharmacy and medication-related problems in patients with SCI seen at an interprofessional primary care clinic. Use of high-risk medications, polypharmacy, and medication-related problems in patients with SCI suggest the need for collaborative interprofessional care that includes a pharmacist.
Entities:
Keywords:
Adverse drug reaction; Drug side effects; Pharmacists; Polypharmacy; Spinal cord injury
Authors: Anthony E Chiodo; William M Scelza; Steven C Kirshblum; Lisa-Ann Wuermser; Chester H Ho; Michael M Priebe Journal: Arch Phys Med Rehabil Date: 2007-03 Impact factor: 3.966
Authors: R Mann; C Schaefer; A Sadosky; F Bergstrom; R Baik; B Parsons; S Nalamachu; B R Stacey; M Tuchman; A Anschel; E C Nieshoff Journal: Spinal Cord Date: 2013-04-16 Impact factor: 2.772
Authors: N Yıldız; Y Akkoç; B Erhan; B Gündüz; B Yılmaz; R Alaca; H Gök; K Köklü; M Ersöz; E Cınar; H Karapolat; N Catalbaş; A N Bardak; I Turna; Y Demir; S Güneş; E Alemdaroğlu; H Tunç Journal: Spinal Cord Date: 2014-04-15 Impact factor: 2.772
Authors: Lewis W Chan; Tomas L Griebling; Edwin P Arnold; Peggy S Chu; Peter W New; Adrian Wagg Journal: World J Urol Date: 2018-07-12 Impact factor: 4.226
Authors: Sara J T Guilcher; Amanda C Everall; Tejal Patel; Tanya L Packer; Sander L Hitzig; Aisha K Lofters Journal: J Spinal Cord Med Date: 2019-10 Impact factor: 1.985
Authors: Kylie J Nabata; Emmanuel K Tse; Tom E Nightingale; Amanda H X Lee; Janice J Eng; Matthew Querée; Matthias Walter; Andrei V Krassioukov Journal: Curr Neuropharmacol Date: 2021 Impact factor: 7.363
Authors: Sara J T Guilcher; Amanda C Everall; Tejal Patel; Tanya L Packer; Sander L Hitzig; Stephanie R Cimino; Aisha K Lofters Journal: BMC Neurol Date: 2020-01-15 Impact factor: 2.474